Study of the stability of proteoliposomes as vehicles for vaccines against Neisseria meningitidis based on recombinant porin complexes

International Journal of Pharmaceutics - Tập 443 - Trang 1-8 - 2013
Paula Freixeiro1, Ernesto Diéguez-Casal1, Liliana Costoya1, Begoña Seijo2, Carlos M. Ferreirós1, María Teresa Criado1, Sandra Sánchez1
1Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain
2Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain

Tài liệu tham khảo

Arenas, 2010, Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity, Clin. Vaccine Immunol., 17, 487, 10.1128/CVI.00423-09 Arigita, 2003, Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomas, Vaccine, 21, 950, 10.1016/S0264-410X(02)00546-7 Arigita, 2005, Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives, Vaccine, 23, 5091, 10.1016/j.vaccine.2005.06.001 Carmenate, 2001, Recombinant Opc protein from Neisseria meningitidis reconstituted into liposomes elicits opsonic antibodies following immunization, Biotechnol. Appl. Biochem., 34, 63, 10.1042/BA20010008 Chatterjee, 2002, Preparation, isolation, and characterization of liposomes containing natural and synthetic lipids, Methods Mol. Biol., 199, 13 Claassen, 1996, Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine, Vaccine, 14, 1001, 10.1016/0264-410X(96)00020-5 Christodoulides, 1998, Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci, Microbiology, 144, 3027, 10.1099/00221287-144-11-3027 Fernández-Urrusuno, 1999, Development of a freeze-dried formulation of insulin-loaded nanoparticles intended for nasal administration, S. T. P. Pharma Sci., 9, 429 Finne, 1982, Antigenic similarities between braincomponents and bacteria causing meningitidis: implications for vaccine development and pathogenesis, Lancet, 2, 355 Freixeiro, P., Diéguez-Casal, E., Costoya, L., Marzoa, J., Ferreirós, C.M., Criado, M.T., Sánchez, S., 2012. High resolution clear native electrophoresis (hrCNE) allows a detailed analysis of the heterotrimeric structure of recombinant Neisseria meningitidis porins inserted into liposomes. J. Proteome Res., http://dx.doi.org/10.1021/pr3008573. Gregoriadis, 2000, Liposomes as immunological adjuvants and vaccine carriers, 137 Grizot, 2004, Structure of the OmpA-like domain of RmpM from Neisseria meningitidis, Mol. Microbiol., 51, 1027, 10.1111/j.1365-2958.2003.03903.x Heikal, 2009, The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides, Cryobiology, 58, 37, 10.1016/j.cryobiol.2008.10.125 Huang, 2007, Infection-induced antibodies against the major outer membrane protein of Campylobacter jejuni mainly recognize conformational epitopes, FEMS Microbiol. Lett., 272, 137, 10.1111/j.1574-6968.2007.00752.x Humphries, 2006, Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis, Vaccine, 24, 36, 10.1016/j.vaccine.2005.07.056 Ito, 2003, Immunodominance of conformation-dependent B-cell epitopes of protein antigens, Biochem. Biophys. Res. Commun., 308, 770, 10.1016/S0006-291X(03)01466-9 Janse, 2000, Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis, Biochim. Biophys. Acta, 1464, 284, 10.1016/S0005-2736(00)00155-3 Kan, 2011, A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect, J. Drug. Deliv., 629234 Kundu, 2011, Stability of lyophilized siRNA nanosome formulations, Int. J. Pharm., 423, 525, 10.1016/j.ijpharm.2011.11.040 Marzoa, 2012, Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis, Vaccine, 30, 2387, 10.1016/j.vaccine.2011.08.123 Marzoa, 2009, Identification of Neisseria meningitidis outer membrane vesicle complexes using 2-D high resolution clear native/SDS-PAGE, J. Proteome Res., 9, 611, 10.1021/pr9006409 Massari, 2005, Improved purification of native meningococcal porin PorB and studies on its structure/function, Protein Expr. Purif., 44, 136, 10.1016/j.pep.2005.04.021 Mayer, 1986, Vesicles of variable sizes produced by a rapid extrusion procedure, Biochim. Biophys. Acta, 858, 161, 10.1016/0005-2736(86)90302-0 Neuhoff, 1985, Clear background and highly sensitive protein staining with Coomassie Blue dyes in polyacrilamide gels: a systematic analysis, Electrophoresis, 6, 427, 10.1002/elps.1150060905 Niebla, 2001, Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded into phospholipid vesicles and detergent, Vaccine, 19, 3568, 10.1016/S0264-410X(01)00008-1 Olson, 1979, Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes, Biochim. Biophys. Acta, 557, 9, 10.1016/0005-2736(79)90085-3 Parmar, 1999, Incorporation of bacterial membrane proteins into liposomes: factors influencing protein reconstitution, Biochim. Biophys. Acta, 1421, 77, 10.1016/S0005-2736(99)00118-2 Prinz, 2000, Associotion of iron-regulated outer membrana proteins of Nisseria meningitidis with the RmpM (class 4) protein, FEMS Microbiol. Lett., 183, 49, 10.1111/j.1574-6968.2000.tb08932.x Reisinger, 2009, Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra, Clin. Vaccine Immunol., 16, 1810, 10.1128/CVI.00207-09 Riguard, 2003, Reconstitution of membrane proteins into liposomes, 65 Rosenqvist, 1999, Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis, Infect. Immun., 67, 1267, 10.1128/IAI.67.3.1267-1276.1999 Sambrook, 1989 Sánchez, 2006, Cross-linking analysis of antigenic outer membrane protein complexes of Neisseria meningitidis, Res. Microbiol., 157, 136, 10.1016/j.resmic.2005.06.011 Sánchez, 2009, Characterisation and immune responses to meningococcal recombinant porin complex incorporated into liposomes, Vaccine, 27, 5338, 10.1016/j.vaccine.2009.06.086 Sharom, 2003, Reconstitution of membrane transporters, Methods Mol. Biol., 227, 129 Smith, 1985, Measurent of protein using Bicinchonic acid, Anal. Biochem., 150, 76, 10.1016/0003-2697(85)90442-7 Stark, 2010, Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure, Eur. J. Pharm. Sci., 41, 546, 10.1016/j.ejps.2010.08.010 Uli, 2006, Outer membrane vesicles of the VA-MENGOC-BC® vaccine againnst serogroup B of Neisseta meningitidis: analysis of proteins components by two-dimensional gel electrophoresis and mass spectrometry, Proteomics, 6, 3389, 10.1002/pmic.200500502 Weynants, 2007, Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis, Infect. Immun., 75, 5434, 10.1128/IAI.00411-07 Wittig, 2007, High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complex, Mol. Cell. Proteomics, 6, 1215, 10.1074/mcp.M700076-MCP200 Wright, 2002, Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitides, Infect. Immun., 70, 4028, 10.1128/IAI.70.8.4028-4034.2002